F. A. Bonilla and H. C. Oettgen, Adaptive immunity, The Journal of allergy and clinical immunology, vol.125, issue.2, pp.33-40, 2010.

G. W. Litman, J. P. Rast, and S. D. Fugmann, The origins of vertebrate adaptive immunity, Nature reviews Immunology, vol.10, issue.8, pp.543-53, 2010.

M. D. Cooper and M. N. Alder, The evolution of adaptive immune systems, Cell, vol.124, issue.4, pp.815-837, 2006.

K. Murphy and C. Weaver, Janeway's immunobiology2017

J. A. Owen, J. Kuby, J. Punt, S. A. Stranford, . Immunology et al., , 2013.

J. E. Smith-garvin, G. A. Koretzky, and M. S. Jordan, T cell activation. Annual review of immunology, vol.27, pp.591-619, 2009.

M. Wieczorek, E. T. Abualrous, J. Sticht, A. , M. Stolzenberg et al.,

, Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation, Frontiers in immunology, vol.8, p.292, 2017.

J. Rossjohn, S. Gras, J. J. Miles, S. J. Turner, D. I. Godfrey et al., T cell antigen receptor recognition of antigen-presenting molecules, Annual review of immunology, vol.33, pp.169-200, 2015.

U. Koch and F. Radtke, Mechanisms of T cell development and transformation. Annual review of cell and developmental biology, vol.27, pp.539-62, 2011.

H. Yamane and W. E. Paul, Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets, Immunological reviews, vol.252, issue.1, pp.12-23, 2013.

J. Zhu, H. Yamane, and W. E. Paul, Differentiation of effector CD4 T cell populations (*)

, Annual review of immunology, vol.28, pp.445-89, 2010.

J. F. Zambrano-zaragoza, E. J. Romo-martinez, J. Duran-avelar-mde, N. Garcia-magallanes, and N. Vibanco-perez, Th17 cells in autoimmune and infectious diseases, International journal of inflammation, p.651503, 2014.

S. Z. Josefowicz, L. F. Lu, A. Y. Rudensky, C. J. Workman, A. L. Szymczak-workman et al., Regulatory T cells: mechanisms of differentiation and function. Annual review of immunology, Cellular and molecular life sciences : CMLS, vol.30, issue.16, pp.2603-2625, 2009.

N. Zhang and M. J. Bevan, CD8(+) T cells: foot soldiers of the immune system, Immunity, vol.35, issue.2, pp.161-169, 2011.

M. H. Andersen, D. Schrama, T. Straten, P. Becker, and J. C. , Cytotoxic T cells, The Journal of investigative dermatology, vol.126, issue.1, pp.32-41, 2006.

D. L. Farber, N. A. Yudanin, and N. P. Restifo, Human memory T cells: generation, compartmentalization and homeostasis, Nature reviews Immunology, vol.14, issue.1, pp.24-35, 2014.

K. D. Omilusik and A. W. Goldrath, The origins of memory T cells, Nature, vol.552, issue.7685, pp.337-346, 2017.

F. Sallusto, J. Geginat, and A. Lanzavecchia, Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual review of immunology, vol.22, pp.745-63, 2004.

C. O. Park and T. S. Kupper, The emerging role of resident memory T cells in protective immunity and inflammatory disease, Nature medicine, vol.21, issue.7, pp.688-97, 2015.

M. D. Cooper, The early history of B cells, Nature reviews Immunology, vol.15, issue.3, pp.191-198, 2015.

M. J. Taussig, Molecular genetics of immunoglobulins, Immunology Supplement, vol.1, pp.7-15, 1988.

J. Stavnezer, J. E. Guikema, and C. E. Schrader, Mechanism and regulation of class switch recombination, Annual review of immunology, vol.26, pp.261-92, 2008.

H. W. Schroeder and L. Cavacini, Structure and function of immunoglobulins, The Journal of allergy and clinical immunology, vol.125, issue.2, pp.41-52, 2010.

V. Seda and M. Mraz, B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells, European journal of haematology, vol.94, issue.3, pp.193-205, 2015.

K. Wang, G. Wei, and D. Liu, CD19: a biomarker for B cell development, lymphoma diagnosis and therapy, Experimental hematology & oncology, vol.1, issue.1, p.36, 2012.

T. W. Lebien and T. F. Tedder, B lymphocytes: how they develop and function, Blood, vol.112, issue.5, pp.1570-80, 2008.

A. K. Cuss, D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols et al., Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity, Journal of immunology, vol.176, issue.3, pp.1506-1522, 2006.

Z. Hua and B. Hou, TLR signaling in B-cell development and activation, Cellular & molecular immunology, vol.10, issue.2, pp.103-109, 2013.

S. L. Nutt, P. D. Hodgkin, D. M. Tarlinton, and L. M. Corcoran, The generation of antibodysecreting plasma cells, Nature reviews Immunology, vol.15, issue.3, pp.160-71, 2015.

T. Kurosaki, K. Kometani, and W. Ise, Memory B cells, Nature reviews Immunology, vol.15, issue.3, pp.149-59, 2015.

H. D. Ochs and W. H. Hitzig, History of primary immunodeficiency diseases. Current opinion in allergy and clinical immunology, vol.12, pp.577-87, 2012.

A. A. Bousfiha, L. Jeddane, F. Ailal, I. Benhsaien, N. Mahlaoui et al., Primary immunodeficiency diseases worldwide: more common than generally thought, Journal of clinical immunology, vol.33, issue.1, pp.1-7, 2013.

M. S. Lim and E. Ks, The molecular pathology of primary immunodeficiencies, The Journal of molecular diagnostics : JMD, vol.6, issue.2, pp.59-83, 2004.

C. Picard, W. Al-herz, A. Bousfiha, J. L. Casanova, T. Chatila et al., Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency, Journal of clinical immunology, vol.35, issue.8, pp.696-726, 2015.

G. Uzel, E. P. Sampaio, M. G. Lawrence, A. P. Hsu, M. Hackett et al., Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulationpolyendocrinopathy-enteropathy-X-linked-like syndrome, The Journal of allergy and clinical immunology, vol.131, issue.6, pp.1611-1634, 2013.

A. Fischer, L. D. Notarangelo, B. Neven, M. Cavazzana, and J. M. Puck, Severe combined immunodeficiencies and related disorders, Nature reviews Disease primers, vol.1, p.15061, 2015.

E. Sieni, V. Cetica, Y. Hackmann, M. L. Coniglio, M. Da-ros et al., Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning, Frontiers in immunology, vol.5, p.167, 2014.

A. Durandy, S. Kracker, and A. Fischer, Primary antibody deficiencies, Nature reviews Immunology, vol.13, issue.7, pp.519-552, 2013.

L. Moroni, I. Bianchi, A. Lleo, and . Geoepidemiology, Autoimmunity reviews, vol.11, issue.6-7, pp.386-92, 2012.

W. Rae, D. Ward, C. J. Mattocks, Y. Gao, R. J. Pengelly et al.,

, Autoimmunity/inflammation in a monogenic primary immunodeficiency cohort, Clinical & translational immunology, vol.6, issue.9, p.155, 2017.

M. Fernandez-castro, S. Mellor-pita, M. J. Citores, P. Munoz, P. Tutor-ureta et al., Common variable immunodeficiency in systemic lupus erythematosus. Seminars in arthritis and rheumatism, vol.36, pp.238-283, 2007.

C. Cunningham-rundles, The many faces of common variable immunodeficiency

, Hematology American Society of Hematology Education Program, vol.2012, pp.301-306, 2012.

X. Xiao, Q. Miao, C. Chang, M. E. Gershwin, and X. Ma, Common variable immunodeficiency and autoimmunity--an inconvenient truth, Autoimmunity reviews, vol.13, issue.8, pp.858-64, 2014.

F. A. Bonilla and R. S. Geha, Common variable immunodeficiency, Pediatric research, vol.65, issue.5, pp.13-22, 2009.

J. Boileau, G. Mouillot, L. Gerard, M. Carmagnat, C. Rabian et al., Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study, Journal of autoimmunity, vol.36, issue.1, pp.25-32, 2011.

G. P. Spickett, Current perspectives on common variable immunodeficiency (CVID)

, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, vol.31, issue.4, pp.536-578, 2001.

A. Uluhan, D. Sager, and H. E. Jasin, Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia, The Journal of rheumatology, vol.25, issue.6, pp.1205-1215, 1998.

A. J. Swaak, . Van-den-brink, and . Hg, Common variable immunodeficiency in a patient with systemic lupus erythematosus, Lupus, vol.5, issue.3, pp.242-248, 1996.

J. K. Abbott and E. W. Gelfand, Common Variable Immunodeficiency: Diagnosis, Management, and Treatment. Immunology and allergy clinics of North America, vol.35, pp.637-58, 2015.

J. A. James, Clinical perspectives on lupus genetics: advances and opportunities. Rheumatic diseases clinics of North America, vol.40, pp.413-445, 2014.

K. E. Taylor, S. A. Chung, R. R. Graham, W. A. Ortmann, A. T. Lee et al., Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes, PLoS genetics, vol.7, issue.2, p.1001311, 2011.

S. M. Al-mayouf, A. Sunker, R. Abdwani, S. A. Abrawi, F. Almurshedi et al., Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus, Nature genetics, vol.43, issue.12, pp.1186-1194, 2011.

M. A. Lee-kirsch, M. Gong, D. Chowdhury, L. Senenko, K. Engel et al.,

, Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus, Nature genetics, vol.39, issue.9, pp.1065-1072, 2007.

M. Carneiro-sampaio, B. L. Liphaus, A. A. Jesus, C. A. Silva, J. B. Oliveira et al., Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies, Journal of clinical immunology, vol.28, issue.1, pp.34-41, 2008.

A. P. Manderson, M. Botto, and M. J. Walport, The role of complement in the development of systemic lupus erythematosus, Annual review of immunology, vol.22, pp.431-56, 2004.

G. Monteferrante, M. Giani, and M. Van-den-heuvel, Systemic lupus erythematosus and Wiskott-Aldrich syndrome in an Italian patient, Lupus, vol.18, issue.3, pp.273-280, 2009.

W. Chebbi, W. Alaya, B. Zantour, O. Berriche, M. Kamoun et al.,

, Presse medicale, vol.40, issue.7-8, pp.772-776, 2011.

Y. H. Hong and C. K. Lee, Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma, Rheumatology international, vol.29, issue.5, pp.569-73, 2009.

G. Coutant, J. P. Algayres, H. Bili, and J. P. Daly,

, Annales de medecine interne, vol.148, issue.7, pp.503-507, 1997.

A. Liston, A. Enders, and O. M. Siggs, Unravelling the association of partial T-cell immunodeficiency and immune dysregulation, Nature reviews Immunology, vol.8, issue.7, pp.545-58, 2008.

P. R. Errante, S. F. Perazzio, J. B. Frazao, N. P. Da-silva, and L. E. Andrade, Primary immunodeficiency association with systemic lupus erythematosus: review of literature and lessons learned by the Rheumatology Division of a tertiary university hospital at Sao Paulo, Brazil. Revista brasileira de reumatologia, vol.56, pp.58-68, 2016.

L. J. Zhu, X. Yang, and X. Q. Yu, Anti-TNF-alpha therapies in systemic lupus erythematosus, Journal of biomedicine & biotechnology, p.465898, 2010.

D. Vedove, C. Simon, J. C. Girolomoni, and G. , Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFalpha agents, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol.10, issue.12, pp.889-97, 2012.

R. Sen and D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, vol.46, issue.5, pp.705-721, 1986.

R. Sen and D. Baltimore, Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism, Nature reviews Molecular cell biology, vol.47, issue.6, pp.49-62, 1986.

A. M. Huang, J. Rusch, and M. Levine, An anteroposterior Dorsal gradient in the Drosophila embryo, Genes & development, vol.11, issue.15, pp.1963-73, 1997.

R. Friedman and A. L. Hughes, Molecular evolution of the NF-kappaB signaling system, Immunogenetics, vol.53, pp.964-74, 2002.

M. S. Hayden and S. Ghosh, Shared principles in NF-kappaB signaling, Cell, vol.132, issue.3, pp.344-62, 2008.

S. T. Smale, Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors, Immunological reviews, vol.246, issue.1, pp.193-204, 2012.

C. W. Muller, F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison, Structure of the NFkappa B p50 homodimer bound to DNA, Nature, vol.373, issue.6512, pp.311-318, 1995.

M. Lenardo, J. W. Pierce, and D. Baltimore, Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility, Science, vol.236, issue.4808, pp.1573-1580, 1987.

A. Hoffmann, G. Natoli, and G. Ghosh, Transcriptional regulation via the NF-kappaB signaling module, Oncogene, vol.25, issue.51, pp.6706-6722, 2006.

E. N. Hatada, A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer et al., The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding, Proceedings of the National Academy of Sciences of the United States of America, vol.89, issue.6, pp.2489-93, 1992.

F. E. Chen, D. B. Huang, Y. Q. Chen, G. Ghosh, S. D. Shumway et al., The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain, The Journal of biological chemistry, vol.391, issue.6665, pp.30874-81, 1998.

J. D. Cheng, R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo, Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta. The Journal of experimental medicine, vol.188, pp.1055-62, 1998.

T. T. Huang and S. Miyamoto, Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha, Molecular and cellular biology, vol.21, issue.14, pp.4737-4784, 2001.

R. Dechend, F. Hirano, K. Lehmann, V. Heissmeyer, S. Ansieau et al., The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear coregulators, Oncogene, vol.18, issue.22, pp.3316-3339, 1999.

C. Scheidereit, IkappaB kinase complexes: gateways to NF-kappaB activation and transcription, Oncogene, vol.25, issue.51, pp.6685-705, 2006.

A. Israel, The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harbor perspectives in biology, vol.2, p.158, 2010.

A. S. Shifera, The zinc finger domain of IKKgamma (NEMO) protein in health and disease, Journal of cellular and molecular medicine, vol.14, issue.10, pp.2404-2418, 2010.

D. Silva, N. S. Anderson, M. M. Carette, A. Silva, K. Heise et al., Transcription factors of the alternative NF-kappaB pathway are required for germinal center B-cell development, Proceedings of the National Academy of Sciences of the United States of America, vol.113, issue.32, pp.9063-9071, 2016.

S. C. Sun, The noncanonical NF-kappaB pathway, Immunological reviews, vol.246, issue.1, pp.125-165, 2012.

R. Kiernan, V. Bres, R. W. Ng, M. P. Coudart, E. Messaoudi et al., Postactivation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65, The Journal of biological chemistry, vol.278, issue.4, pp.2758-66, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02239699

V. S. Spiegelman, P. Stavropoulos, E. Latres, M. Pagano, Z. Ronai et al., Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB, The Journal of biological chemistry, vol.276, issue.29, pp.27152-27160, 2001.

T. Kato, M. Delhase, A. Hoffmann, and M. Karin, CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response, Molecular cell, vol.12, issue.4, pp.829-868, 2003.

D. Boraschi and A. Tagliabue, The interleukin-1 receptor family, Seminars in immunology, vol.25, issue.6, pp.394-407, 2013.

N. Shembade, A. Ma, and E. W. Harhaj, Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes, Science, vol.327, issue.5969, pp.1135-1144, 2010.

R. M. Locksley, N. Killeen, and M. J. Lenardo, The TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, vol.104, issue.4, pp.487-501, 2001.

H. Hsu, H. B. Shu, M. G. Pan, and D. V. Goeddel, TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways, Cell, vol.84, issue.2, pp.299-308, 1996.

S. C. Sun, Non-canonical NF-kappaB signaling pathway, Cell research, vol.21, issue.1, pp.71-85, 2011.

C. F. Ware, Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways, Immunological reviews, vol.223, pp.186-201, 2008.

E. Cheng, T. G. Whitsett, N. L. Tran, and J. A. Winkles, The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion, Molecular cancer research : MCR, vol.13, issue.3, pp.575-83, 2015.

D. Wang, R. Matsumoto, Y. You, C. T. Lin, X. Y. Gaffen et al., , p.28

, NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1, Molecular and cellular biology, vol.24, issue.1, pp.164-71, 2004.

R. Weil and A. Israel, T-cell-receptor-and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes, Current opinion in immunology, vol.16, issue.3, pp.374-81, 2004.

A. A. Habib, S. Chatterjee, S. K. Park, R. R. Ratan, S. Lefebvre et al., The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptortyrosine kinase signalosome, The Journal of biological chemistry, vol.276, issue.12, pp.8865-74, 2001.

G. Bonizzi and M. Karin, The two NF-kappaB activation pathways and their role in innate and adaptive immunity, Trends in immunology, vol.25, issue.6, pp.280-288, 2004.

M. Nishikori, Classical and Alternative NF.KAPPA.B Activation Pathways and Their Roles in Lymphoid Malignancies2005, p.p

E. Alcamo, N. Hacohen, L. C. Schulte, P. D. Rennert, R. O. Hynes et al., Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs. The Journal of experimental medicine, vol.195, pp.233-277, 2002.

R. E. Mebius, Organogenesis of lymphoid tissues, Nature reviews Immunology, vol.3, issue.4, pp.292-303, 2003.

M. Dalod, R. Chelbi, B. Malissen, and T. Lawrence, Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming, The EMBO journal, vol.33, issue.10, pp.1104-1120, 2014.

S. Gerondakis and U. Siebenlist, Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harbor perspectives in biology, vol.2, p.182, 2010.

S. Gerondakis, M. Grossmann, Y. Nakamura, T. Pohl, and R. Grumont, Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts, Oncogene, vol.18, issue.49, pp.6888-95, 1999.

S. Gerondakis, R. Grumont, I. Rourke, and M. Grossmann, The regulation and roles of

, Rel/NF-kappa B transcription factors during lymphocyte activation, Current opinion in immunology, vol.10, issue.3, pp.353-362, 1998.

M. S. Hayden, A. P. West, and S. Ghosh, NF-kappaB and the immune response, Oncogene, vol.25, issue.51, pp.6758-80, 2006.

P. De-togni, J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick et al., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin, Science, vol.264, issue.5159, pp.703-710, 1994.

P. A. Koni, R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle et al., Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin betadeficient mice, Immunity, vol.6, issue.4, pp.491-500, 1997.

J. H. Caamano, C. A. Rizzo, S. K. Durham, D. S. Barton, C. Raventos-suarez et al., Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. The Journal of experimental medicine, vol.187, pp.185-96, 1998.

H. D. Brightbill, J. K. Jackman, E. Suto, H. Kennedy, C. Jones et al., Conditional Deletion of NF-kappaB-Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation, Journal of immunology, vol.195, issue.3, pp.953-64, 2015.

T. Kawabe, T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara et al., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation, Immunity, vol.1, issue.3, pp.167-78, 1994.

G. Franzoso, L. Carlson, L. Poljak, E. W. Shores, S. Epstein et al., Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture, The Journal of experimental medicine, vol.187, issue.2, pp.147-59, 1998.

C. M. Snapper, F. R. Rosas, P. Zelazowski, M. A. Moorman, M. R. Kehry et al., B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. The Journal of experimental medicine, vol.184, pp.1537-1578, 1996.

M. Hahn, A. Macht, A. Waisman, and N. Hovelmeyer, NF-kappaB-inducing kinase is essential for B-cell maintenance in mice, European journal of immunology, vol.46, issue.3, pp.732-773, 2016.

T. Gruber, C. Pfeifhofer-obermair, and G. Baier, PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytes, Immunology letters, vol.132, issue.1-2, pp.6-11, 2010.

T. Egawa, B. Albrecht, B. Favier, M. J. Sunshine, K. Mirchandani et al., Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation, Current biology : CB, vol.13, issue.14, pp.1252-1260, 2003.

J. Ruland, G. S. Duncan, A. Wakeham, and T. W. Mak, Differential requirement for Malt1 in T and B cell antigen receptor signaling, Immunity, vol.19, issue.5, pp.749-58, 2003.

J. Ruland, G. S. Duncan, E. A. Del-barco-barrantes, I. Nguyen, L. Plyte et al., Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure, Cell, vol.104, issue.1, pp.33-42, 2001.

L. M. Kingeter and B. C. Schaefer, Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset, Journal of immunology, vol.181, issue.9, pp.6244-54, 2008.

I. M. Verma, J. K. Stevenson, E. M. Schwarz, D. Van-antwerp, and S. Miyamoto, Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation, Genes & development, vol.9, issue.22, pp.2723-2758, 1995.

S. Y. Pai and I. C. Ho, c-Rel delivers a one-two punch in Th1 cell differentiation, The Journal of clinical investigation, vol.110, issue.6, pp.741-743, 2002.

E. S. Hwang, J. H. Hong, and L. H. Glimcher, IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. The Journal of experimental medicine, vol.202, pp.1289-300, 2005.

D. S. Weih, Z. B. Yilmaz, and F. Weih, Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines, Journal of immunology, vol.167, issue.4, pp.1909-1928, 2001.

D. Jurk, C. Wilson, J. F. Passos, F. Oakley, C. Correia-melo et al., Chronic inflammation induces telomere dysfunction and accelerates ageing in mice, Nature communications, vol.2, p.4172, 2014.

B. Goudeau, F. Huetz, S. Samson, D. Santo, J. P. Cumano et al.,

, IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival, Proceedings of the National Academy of Sciences of the United States of America, vol.100, issue.26, pp.15800-15805, 2003.

M. Schmidt-supprian, G. Courtois, J. Tian, A. J. Coyle, A. Israel et al., Mature T cells depend on signaling through the IKK complex, Immunity, vol.19, issue.3, pp.377-89, 2003.

A. M. Rowe, S. E. Murray, H. P. Raue, Y. Koguchi, M. K. Slifka et al., A cell-intrinsic requirement for NF-kappaB-inducing kinase in CD4 and CD8 T cell memory, Journal of immunology, vol.191, issue.7, pp.3663-72, 2013.

I. Vikstrom, S. Carotta, K. Luthje, V. Peperzak, P. J. Jost et al., Mcl-1 is essential for germinal center formation and B cell memory, Science, vol.330, issue.6007, pp.1095-1104, 2010.

C. Chen, L. C. Edelstein, and C. Gelinas, The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L), Molecular and cellular biology, vol.20, issue.8, pp.2687-95, 2000.

Y. Grinberg-bleyer, H. Oh, A. Desrichard, D. M. Bhatt, R. Caron et al., NF-kappaB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer, Cell, vol.170, issue.6, pp.1096-108, 2017.

Q. Zhang, M. J. Lenardo, and D. Baltimore, 30 Years of NF-kappaB: A Blossoming of Relevance to Human Pathobiology, Cell, vol.168, issue.1-2, pp.37-57, 2017.

Y. Xia, S. Shen, and I. M. Verma, NF-kappaB, an active player in human cancers, Cancer immunology research, vol.2, issue.9, pp.823-853, 2014.

A. Smahi, G. Courtois, P. Vabres, S. Yamaoka, S. Heuertz et al., Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium, Nature, vol.405, issue.6785, pp.466-72, 2000.

M. Schmidt-supprian, W. Bloch, G. Courtois, K. Addicks, A. Israel et al.,

, NEMO/IKK gamma-deficient mice model incontinentia pigmenti, Molecular cell, vol.5, issue.6, pp.981-92, 2000.

R. Doffinger, A. Smahi, C. Bessia, F. Geissmann, J. Feinberg et al., X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling, Nature genetics, vol.27, issue.3, pp.277-85, 2001.

J. Lahtela, H. O. Nousiainen, V. Stefanovic, J. Tallila, H. Viskari et al., Mutant CHUK and severe fetal encasement malformation. The New England journal of medicine, vol.363, pp.1631-1638, 2010.

U. Pannicke, B. Baumann, S. Fuchs, P. Henneke, A. Rensing-ehl et al., Deficiency of innate and acquired immunity caused by an IKBKB mutation. The New England journal of medicine, vol.369, pp.2504-2518, 2013.

T. Mousallem, J. Yang, T. J. Urban, H. Wang, M. Adeli et al., A nonsense mutation in IKBKB causes combined immunodeficiency, Blood, vol.124, issue.13, pp.2046-50, 2014.

A. L. Snow, W. Xiao, J. R. Stinson, W. Lu, B. Chaigne-delalande et al.,

, Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. The Journal of experimental medicine, vol.209, pp.2247-61, 2012.

D. Buchbinder, J. R. Stinson, D. J. Nugent, L. Heurtier, F. Suarez et al., Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation, The Journal of allergy and clinical immunology, vol.136, issue.3, pp.819-840, 2015.

J. Greil, T. Rausch, T. Giese, O. R. Bandapalli, V. Daniel et al., Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency, The Journal of allergy and clinical immunology, vol.131, issue.5, pp.1376-83, 2013.

F. Charbit-henrion, A. K. Jeverica, B. Begue, G. Markelj, M. Parlato et al., Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome, Journal of pediatric gastroenterology and nutrition, vol.64, issue.3, pp.378-84, 2017.

H. H. Jabara, T. Ohsumi, J. Chou, M. J. Massaad, H. Benson et al., A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency, The Journal of allergy and clinical immunology, vol.132, issue.1, pp.151-159, 2013.

J. M. Torres, R. Martinez-barricarte, S. Garcia-gomez, M. S. Mazariegos, Y. Itan et al., Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity, The Journal of clinical investigation, vol.124, issue.12, pp.5239-5287, 2014.

Q. Zhou, H. Wang, D. M. Schwartz, M. Stoffels, Y. H. Park et al., Loss-offunction mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease, Nature genetics, vol.48, issue.1, pp.67-73, 2016.

G. Courtois, A. Smahi, J. Reichenbach, R. Doffinger, C. Cancrini et al., A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency, The Journal of clinical investigation, vol.112, issue.7, pp.1108-1123, 2003.

J. L. Mooster, L. Bras, S. Massaad, M. J. Jabara, H. Yoon et al., Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IkappaBalpha, The Journal of experimental medicine, vol.212, issue.2, pp.185-202, 2015.

L. F. Schimke, N. Rieber, S. Rylaarsdam, O. Cabral-marques, N. Hubbard et al., A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy, Journal of clinical immunology, vol.33, issue.6, pp.1088-99, 2013.

H. Boztug, T. Hirschmugl, W. Holter, K. Lakatos, L. Kager et al., NF-kappaB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation, Journal of clinical immunology, vol.36, issue.6, pp.533-573, 2016.

M. Fliegauf, V. L. Bryant, N. Frede, C. Slade, S. T. Woon et al., Haploinsufficiency of the NF-kappaB1 Subunit p50 in Common Variable Immunodeficiency, American journal of human genetics, vol.97, issue.3, pp.389-403, 2015.

C. E. Lee, D. A. Fulcher, B. Whittle, R. Chand, N. Fewings et al., Autosomaldominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100, Blood, vol.124, issue.19, pp.2964-72, 2014.

K. Chen, E. M. Coonrod, A. Kumanovics, Z. F. Franks, J. D. Durtschi et al., Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency, American journal of human genetics, vol.93, issue.5, pp.812-836, 2013.

V. Lougaris, G. Tabellini, M. Vitali, M. Baronio, O. Patrizi et al., Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease, The Journal of allergy and clinical immunology, vol.135, issue.6, pp.1641-1644, 2015.

K. L. Willmann, S. Klaver, F. Dogu, E. Santos-valente, W. Garncarz et al., Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity, Nature communications, vol.5, p.5360, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02181338

N. Sharfe, D. Merico, A. Karanxha, C. Macdonald, H. Dadi et al., The effects of RelB deficiency on lymphocyte development and function, Journal of autoimmunity, vol.65, pp.90-100, 2015.

D. Merico, N. Sharfe, P. Hu, J. Herbrick, and C. M. Roifman, RelB deficiency causes combined immunodeficiency, LymphoSign Journal, vol.2, issue.3, pp.147-55, 2015.

Y. R. Badran, F. Dedeoglu, L. Castillo, J. M. Bainter, W. Ohsumi et al., Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. The Journal of experimental medicine, vol.214, pp.1937-1984, 2017.

A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore, Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B, Nature, vol.376, issue.6536, pp.167-70, 1995.

W. A. Comrie, A. J. Faruqi, S. Price, Y. Zhang, V. K. Rao et al., RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias, The Journal of allergy and clinical immunology, 2018.

J. D. Watson and F. H. Crick, Cold Spring Harbor symposia on quantitative biology, vol.18, pp.123-154, 1953.

S. Goodwin, J. D. Mcpherson, and W. R. Mccombie, Coming of age: ten years of nextgeneration sequencing technologies, Nature reviews Genetics, vol.17, issue.6, pp.333-51, 2016.

J. Shendure and H. Ji, Next-generation DNA sequencing, Nature biotechnology, vol.26, issue.10, pp.1135-1180, 2008.

G. Project, C. Abecasis, G. R. Auton, A. Brooks, L. D. Depristo et al., An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, issue.7422, pp.56-65, 2012.

A. Belkadi, A. Bolze, Y. Itan, A. Cobat, Q. B. Vincent et al., Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants, Proceedings of the National Academy of Sciences of the United States of America, vol.112, issue.17, pp.5473-5481, 2015.

J. K. Teer and J. C. Mullikin, Exome sequencing: the sweet spot before whole genomes, Human molecular genetics, vol.19, issue.R2, pp.145-51, 2010.

S. B. Ng, K. J. Buckingham, C. Lee, A. W. Bigham, H. K. Tabor et al., Exome sequencing identifies the cause of a mendelian disorder, Nature genetics, vol.42, issue.1, pp.30-35, 2010.

M. Choi, U. I. Scholl, J. W. Liu, T. Tikhonova, I. R. Zumbo et al., Genetic diagnosis by whole exome capture and massively parallel DNA sequencing, Proceedings of the National Academy of Sciences of the United States of America, vol.106, issue.45, pp.19096-101, 2009.

K. Bodi, A. G. Perera, P. S. Adams, D. Bintzler, K. Dewar et al., Comparison of commercially available target enrichment methods for next-generation sequencing, Journal of biomolecular techniques : JBT, vol.24, issue.2, pp.73-86, 2013.

A. Belkadi, V. Pedergnana, A. Cobat, Y. Itan, Q. B. Vincent et al., Wholeexome sequencing to analyze population structure, parental inbreeding, and familial linkage, Proceedings of the National Academy of Sciences of the United States of America, vol.113, issue.24, pp.6713-6721, 2016.

H. K. Tabor, N. J. Risch, and R. M. Myers, Candidate-gene approaches for studying complex genetic traits: practical considerations, Nature reviews Genetics, vol.3, issue.5, pp.391-398, 2002.

I. A. Adzhubei, S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova et al., A method and server for predicting damaging missense mutations, Nature methods, vol.7, issue.4, pp.248-257, 2010.

P. C. Ng and S. Henikoff, SIFT: predicting amino acid changes that affect protein function, Nucleic Acids Research, vol.31, issue.13, pp.3812-3816, 2003.

M. Kircher, D. M. Witten, P. Jain, B. J. O'roak, G. M. Cooper et al., A general framework for estimating the relative pathogenicity of human genetic variants, Nature genetics, vol.46, issue.3, pp.310-315, 2014.

Y. Choi and A. P. Chan, PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels, Bioinformatics, vol.31, issue.16, pp.2745-2752, 2015.

M. Zhu and S. Zhao, Candidate gene identification approach: progress and challenges. International journal of biological sciences, vol.3, pp.420-427, 2007.

J. T. Merrill, C. M. Neuwelt, D. J. Wallace, J. C. Shanahan, K. M. Latinis et al., Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial, Arthritis and rheumatism, vol.62, issue.1, pp.222-255, 2010.

B. H. Rovin, R. Furie, K. Latinis, R. J. Looney, F. C. Fervenza et al., Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study, Arthritis and rheumatism, vol.64, issue.4, pp.1215-1241, 2012.

A. Psarras, M. Yusof, M. Y. El-sherbiny, Y. M. Hensor, E. M. Wittmann et al.,

, Distinct subsets of interferon-stimulated genes are associated with incomplete and established systemic lupus erythematosus. Annals of the rheumatic diseases, vol.75, p.72, 2016.

W. M. Schneider, M. D. Chevillotte, and C. M. Rice, Interferon-stimulated genes: a complex web of host defenses, Annual review of immunology, vol.32, pp.513-558, 2014.

G. I. Rice, G. M. Forte, M. Szynkiewicz, D. S. Chase, A. Aeby et al., Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, The Lancet Neurology, vol.12, issue.12, pp.1159-69, 2013.

Y. Liu, A. A. Jesus, B. Marrero, D. Yang, S. E. Ramsey et al., Activated STING in a vascular and pulmonary syndrome. The New England journal of medicine, vol.371, pp.507-525, 2014.

N. Jeremiah, B. Neven, M. Gentili, I. Callebaut, S. Maschalidi et al., Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations, The Journal of clinical investigation, vol.124, issue.12, pp.5516-5536, 2014.

R. Schwab, M. K. Crow, C. Russo, and M. E. Weksler, Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1, Journal of immunology, vol.135, issue.3, pp.1714-1722, 1985.

P. Tuijnenburg, L. Allen, H. Burns, S. O. Greene, D. Jansen et al., Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans, The Journal of allergy and clinical immunology, 2018.

Y. Liu, S. Hanson, P. Gurugama, A. Jones, B. Clark et al., Novel NFKB2 mutation in early-onset CVID, Journal of clinical immunology, vol.34, issue.6, pp.686-90, 2014.

C. Shi, F. Wang, A. Tong, X. Q. Zhang, H. M. Song et al., NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature, Medicine, vol.95, issue.40, p.5081, 2016.

J. Banchereau and V. Pascual, Type I interferon in systemic lupus erythematosus and other autoimmune diseases, Immunity, vol.25, issue.3, pp.383-92, 2006.

J. Wang, S. H. Basagoudanavar, X. Wang, E. Hopewell, R. Albrecht et al., NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication, Journal of immunology, vol.185, issue.3, pp.1720-1729, 2010.

X. Wang, S. Hussain, E. J. Wang, X. Wang, M. O. Li et al., Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression, Journal of immunology, vol.178, issue.11, pp.6770-6776, 2007.

B. S. Kochupurakkal, Z. C. Wang, T. Hua, A. C. Culhane, S. J. Rodig et al., RelA-Induced Interferon Response Negatively Regulates Proliferation, PloS one, vol.10, issue.10, p.140243, 2015.

D. G. Saliba, A. Heger, H. L. Eames, S. Oikonomopoulos, A. Teixeira et al., RelA interaction targets inflammatory genes in macrophages, Cell reports, vol.8, issue.5, pp.1308-1325, 2014.

T. Krausgruber, D. Saliba, G. Ryzhakov, A. Lanfrancotti, K. Blazek et al., IRF5 is required for late-phase TNF secretion by human dendritic cells, Blood, vol.115, issue.22, pp.4421-4451, 2010.

C. Xu, X. Wu, X. Zhang, Q. Xie, C. Fan et al., Embryonic Lethality and Host Immunity of RelA-Deficient Mice Are Mediated by Both Apoptosis and Necroptosis, Journal of immunology, vol.200, issue.1, pp.271-85, 2018.

S. Erdman, J. G. Fox, C. A. Dangler, D. Feldman, and B. H. Horwitz, Typhlocolitis in NF-kappa B-deficient mice, Journal of immunology, vol.166, issue.3, pp.1443-1450, 2001.

. Sabrina, On a été dos à dos dans le bureau, et ça ne nous a pas empêché de vraiment bien connecté. Tu me permets de me sentir à l'aise et naturel. De m'ouvrir

J. , Je pense que c'est une vraie chance que quelqu'un t'ait comme collègue ou amie. J'ai eu cette chance, et j'espère continuer à l'avoir. Je te souhaite beaucoup de réussite et de bonheur

, Merci d'avoir été un soutien dans les moments les plus difficiles, merci de m'avoir calmé quand j'étais stressé, Loïc, tu as été bienveillant, on a fait beaucoup de blague (de tout genre)

T. M. Sébastien, as soutenu, ma rendu plus réaliste, et m'a fait rire et sortir de mes zones de conforts ;). Ton départ m'a affecté. Merci pour tout mon cher Seb

M. , nos goûts, nos satisfactions, nos indignations, etc. Merci pour les moments profonds mais aussi les rigolades faciles ! Et déjà que tu as un mignon petit Maxime, je suis tellement content que tu attendes une nouvelle perle dans ta vie

H. Shabi, Il y a 5 ans on s'est montré respectueux et on a toujours su être léger et taquin. J'ai vu vos 2 grossesses, qui m'ont empli de bonheur. Vous avez été merveilleuse avec moi

, Shabi la classe et Hanem pleine d'amour, vous allez beaucoup me manquer et je vous adore, vraiment

Z. Julien, E. Ma-petite-soëli, and T. Prendra-bien-soin-de, Merci pour avoir partagé ton savoir et ta sagesse avec moi. Merci d'avoir fait sentir à tout le bureau qu'on était tous égaux. Nous nous sommes senti-e-s estimé

T. Amine, Merci pour ta gentillesse et ton affection. Merci pour ton soutien et ta bienveillance envers moi, ça m'a aidé et rassuré

, Alexandrine, toujours un sourire, un bon mot, tu es la première qui m'a aidé lors de mon arrivée dans l'unité. Merci pour ta gentillesse

. Sarah, Je suis content de te voir heureuse

E. Chantal, Vous avez toujours été disponible quand j'avais besoin d'un conseil ou d'une aide. Votre générosité et sympathie m'a aidé tout au long de ces longues années. Vous avez toujours eu un petit mot de soutien dans les moments difficiles, vous m'avez aidé à progresser, scientifiquement et professionnellement, et je vous en suis très reconnaissant

. Annarita, thank you for your support (each time at the right time)

M. Inès, Merci de m'avoir aidé tranquillement quand j'étais perdu et paniqué. Merci pour les moments de détentes. On a beaucoup ri. C'était cool de venir te voir dans ton bureau avec Melinda et Marie-Claude

A. Cindy,

, Amandine, Manon, Nelly) pour leur soutien, leur entraide et leur tolérance. To the people of IMAGINE who became my friends also outside the institute, I thank you for being there, Enfin, merci à tout le reste de cette très nombreuse équipe et aux anciens de l'équipe (Sylviane

, bienveillance envers moi, j'en suis très reconnaissant. Tu es vraiment un mec bien, comme il y en a rarement

, A mon frère Ahmed Ali, je t'aime "a rass el trombiya ta3i

, And finally, to my friends from outside my scientific life, my dear Friends

A. Ali, . Amine, . Aurélia, . Basma, C. ;. Benjamin et al., Younes, ?, you are family to me, you will recognize yourself in this message: I love you dearly and deeply. I was not able to see you much during this thesis, even those living in Paris. But you have supported me and believed in me. Thank you for being in my life. I wish you all the best in your life. Cheers to the marriage of my beloved Léa & Riad and Dina & Omar, Chloé, Claire (x2)

L. Heurtier, H. Lamrini, L. Chentout, M. C. Deau, A. Bouafia et al.,

, Haematologica, vol.102, issue.7, pp.278-281, 2017.

, Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase ? syndrome 2: A cohort study

E. Elkaim, B. Neven, J. Bruneau, K. Mitsui-sekinaka, A. Stanislas et al.,

, Manuscript for submission: RELA heterozygous dominant mutations are associated with pediatric and familial Systemic Lupus Erythematous, J Allergy Clin Immunol, vol.138, issue.1, pp.210-218, 2016.